BioStem Technologies Announces Corporate Update on Company Direction
29 avr. 2020 12h35 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, April 29, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life sciences company specializing in perinatal tissue-based...
BioAegis Demonstrates Gelsolin Therapy Can Quell the Cytokine Storm and Promote Tissue Repair
27 avr. 2020 01h15 HE
|
BioAegis Therapeutics
MORRISTOWN, N.J., April 27, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. has highlighted recently published gene expression data in animal studies where recombinant human plasma gelsolin...
Arch Biopartners Submits Application to Health Canada to Conduct COVID19 Phase II Human Trial for Metablok to Prevent Lung and Kidney Inflammation
23 avr. 2020 16h54 HE
|
Arch Biopartners
TORONTO, April 23, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) a clinical stage company developing new drug candidates for treating...
Preclinical Study Showing Beneficial Effects of Cymerus™ MSCs in Acute Respiratory Distress Syndrome Accepted for Publication in Leading Peer-Reviewed Journal
17 avr. 2020 08h15 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, April 17, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that...
Small NJ Biotech Firm, BioAegis Therapeutics, Accelerating Multiple Clinical Trial Submissions for Severe COVID-19 Pneumonia Patients
02 avr. 2020 02h15 HE
|
BioAegis Therapeutics
MORRISTOWN, N.J., April 02, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. is a clinical stage, private company focused on developing therapies for infectious, inflammatory, and degenerative...
Orion Biotechnology to Present at the BIO-Europe Spring 2020 Virtual Event
19 mars 2020 10h07 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, March 19, 2020 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage biotechnology company, today announced that it will be presenting an update on the company’s...
Patient Advocate Foundation and Begin Again Foundation Announce Financial Aid Fund
04 avr. 2016 05h15 HE
|
Patient Advocate Foundation
HAMPTON, Va., April 4, 2016 (GLOBE NEWSWIRE) -- In April 2015, PGA Tour golfer Marc Leishman signed the consentform to medically induce his wife, Audrey, into a coma; her only, albeit unlikely, chance...